The question before an appointment is often simple: “What will actually happen?” It is a good question. Anxiety can make unfamiliar medical settings feel larger than they are.
At Invictus Clinic, we believe the details matter. Knowing the shape of a visit can give you something solid to hold before you arrive. IV ketamine for psychiatric uses, including anxiety, is off-label. That means a careful evaluation, informed consent, and individualized planning are essential.
Our work begins with conversation. Not with a promise.
The Consultation Comes Before the Infusion
An IV ketamine appointment is not simply a medication visit. It starts with determining whether treatment is appropriate for you, given your symptoms, health history, current medications, and treatment goals.
During a consultation, we ask about the anxiety you are living with. We also ask about prior mental health care, medication experiences, substance use history, medical conditions, and the support available to you outside the clinic. These are not side questions. They help us understand the full picture.
You may wish to review our approach to anxiety care in Marietta before your visit. Anxiety rarely exists in a vacuum. Sleep, stress, grief, trauma history, work demands, physical health, and relationships can all shape how it feels day to day.
We also discuss the limits of what ketamine can tell us in advance. Research involving ketamine has reported changes in anxiety symptoms among some study participants, but the findings do not make an individual response predictable. A study examining ketamine’s effects on anxiety symptoms found reductions in anxiety measures in adults with mood disorders, while response and clinical context varied (McIntyre et al., 2020).
If you are exploring this option, our page on IV ketamine for anxiety can help you begin thinking through the questions you want to bring to consultation.
Screening Is Part of Safe Care
Ketamine can affect perception, blood pressure, coordination, and judgment during and shortly after an infusion. For that reason, we take screening seriously.
We review whether there are medical or psychiatric factors that may change the risk-benefit discussion. We also want to know about alcohol or other substance use, because ketamine is a controlled medication with misuse potential. Honesty helps here. It does not disqualify you from being heard.
If ketamine is not the right next step, that information is still useful. Good treatment planning sometimes means choosing a different path, or addressing a safety concern first. We may also talk with you about other elements of depression and anxiety care, depending on your needs and clinical history.
Arriving With a Plan for the Rest of Your Day
Once an infusion is scheduled, we encourage you to make the day quieter than usual. Avoid building a demanding schedule around the appointment. You must arrange reliable transportation home. Do not drive, operate machinery, or make important decisions for the remainder of the day after an infusion, or longer if our clinical team instructs you to do so.
Bring a list of medications and questions. Wear comfortable clothing. Let us know if anything in your health has changed since your consultation.
It can also help to think about support before you need it. Some patients prefer a trusted person to check in after the visit. Others want a calm evening, a simple meal, and fewer decisions. There is no single correct way to recover from an appointment. There is only the value of leaving room for yourself.
The Infusion Room Is Designed for Observation
At the appointment, our clinical team prepares you for the infusion and monitors you throughout. We review what to expect, answer questions, and check relevant vital signs. The goal is not to rush you through a protocol. It is to provide structured medical care while you are receiving a medicine that can feel unfamiliar.
During an IV infusion, some people notice changes in sensation, thought patterns, time perception, or emotional distance from anxious material. Others may feel sleepy, lightheaded, nauseated, or temporarily unsettled. Experiences differ. We want you to tell us what you are noticing.
Monitoring is not an afterthought. Clinical recommendations for ketamine administration emphasize appropriate patient selection, medical oversight, and attention to cardiovascular and psychiatric safety during care (Swainson et al., 2021).
We remain present. You are not expected to manage the experience alone.
Anxiety May Feel Different During the Visit
For someone accustomed to constant vigilance, the altered state associated with ketamine can feel strange at first. That is understandable. We encourage you to approach the appointment with curiosity rather than a demand that it feel a certain way.
You do not need to perform calmness. You do not need to find the perfect insight.
Small studies have examined measurable brain-state changes during ketamine treatment in people with generalized and social anxiety, including changes in EEG activity during treatment (Shadli et al., 2018). Those findings are interesting, but they do not define what your experience will be. Your care remains personal.
If you feel discomfort, fear, or physical symptoms, tell us. We can respond in the moment and consider what the experience means for future planning.
Recovery Time Is Still Part of the Appointment
When the infusion ends, we continue to observe you as the immediate effects lessen. We want you alert enough for a safe transition home and able to understand any post-visit instructions.
This is often a quieter part of the day. Some patients feel tired. Some feel reflective. Some feel little change right away. We do not treat the first few minutes after an infusion as a verdict on whether treatment has or has not been meaningful.
Research on ketamine has often focused on depression rather than anxiety, and it shows that timing and durability of effects can vary substantially among participants. A review of clinical ketamine research and response variation describes both the interest in ketamine and the need for careful, ongoing clinical assessment (Yavi et al., 2022). In a placebo-controlled trial of intravenous ketamine in treatment-resistant depression, outcomes varied across dose groups and time points (Fava et al., 2020).
That uncertainty is worth naming plainly.
Planning for What Happens Between Visits
An infusion is one part of care, not the whole of it. Afterward, we discuss what you noticed and how you are functioning in the days that follow. We may ask about sleep, anxiety intensity, mood, physical side effects, and any meaningful changes in your daily life.
For a practical look at the days following treatment, read our guide to the ketamine anxiety timeline. We encourage patients to track their experience without turning every hour into a test.
Your broader care still matters. Therapy, medication management, supportive relationships, rest, and routines may all remain important. Ketamine does not erase the need for a life that supports your health.
What We Want You to Ask Us
A consultation should leave room for your questions. Consider asking:
Why might IV ketamine be considered in my situation?
What risks matter most given my medical and psychiatric history?
What should I do with my current medications before treatment?
What monitoring will occur during my infusion?
How should I plan transportation and support afterward?
What would make us reconsider or pause treatment?
There is no benefit in pretending you are less worried than you are. Anxiety is often the mind’s effort to prepare for uncertainty. We can meet that uncertainty with clear information, attentive monitoring, and a plan made with you.
Frequently Asked Questions
Is IV ketamine for anxiety FDA-approved?
No. IV ketamine for psychiatric conditions, including anxiety, is used off-label. We discuss what off-label care means, along with potential risks, alternatives, and unanswered questions, before treatment is considered.
Will I be awake during the infusion?
People are generally awake, though they may feel drowsy or experience temporary perceptual changes. We monitor you during the appointment and ask you to communicate how you are feeling.
Can I drive myself home?
No. You must arrange transportation home. After an infusion, do not drive, operate machinery, or make important decisions for the remainder of the day. Follow any longer restriction our clinical team gives you.
How quickly will my anxiety change?
There is no reliable timeline for every person. Some people notice changes sooner than others, and some may not experience the change they hoped for. We focus on careful follow-up rather than promises.
What if I feel unsafe or have thoughts of self-harm?
Tell us directly. If you are in immediate danger or experiencing a mental health crisis, call or text the 988 Suicide and Crisis Lifeline at 988, call 911, or go to the nearest emergency department.
If you are considering IV ketamine for anxiety in Marietta, GA, we invite you to reach out to our Marietta ketamine clinic for a consultation. We can talk through your questions, your history, and whether this approach belongs in your care plan.
The information in this article is for educational purposes only and does not constitute medical advice. IV ketamine for psychiatric conditions is off-label and should be pursued only under the supervision of a licensed provider familiar with your medical and psychiatric history.
Works Cited
1. McIntyre RS, et al. The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorder. https://pubmed.ncbi.nlm.nih.gov/32406161/
2. Swainson J, et al. The Canadian Network for Mood and Anxiety Treatments Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder. https://pubmed.ncbi.nlm.nih.gov/33174760/
3. Shadli SM, et al. Ketamine Effects on EEG during Therapy of Treatment-Resistant Generalized Anxiety and Social Anxiety. https://pubmed.ncbi.nlm.nih.gov/29718262/
4. Yavi M, et al. Ketamine treatment for depression: a review. https://pubmed.ncbi.nlm.nih.gov/35509843/
5. Fava M, et al. Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). https://pubmed.ncbi.nlm.nih.gov/30283029/
6. 988 Suicide and Crisis Lifeline. https://988lifeline.org/
Disclaimer
This article is for educational purposes only and is not a substitute for individualized evaluation, diagnosis, or treatment from a qualified healthcare professional.
